Status:
COMPLETED
Neuralized1 and RGS14 Genes
Lead Sponsor:
TC Erciyes University
Conditions:
Autism Spectrum Disorder
High-functioning Autism
Eligibility:
All Genders
2-16 years
Brief Summary
Autism is a broad spectrum neurodevelopmental disease. Some individuals with ADS by high cognitive functions are diagnosed with High Functioning Autism (HFA). In some studies, it has been shown that N...
Detailed Description
ASD is a neurological disease starting in the early stages of life and is characterized by cognitive and behavioral disorders (Ansel et al., 2008;Alvares et al., 2020). It is considered that the etiol...
Eligibility Criteria
Inclusion
- Being diagnosed ASD or HFA patient,
- Being between the ages of 2-16.
Exclusion
- To use medicine,
- Have a other syndromic illness,
- Being younger than 2 years old or over 16 years old.
Key Trial Info
Start Date :
January 10 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04865198
Start Date
January 10 2013
End Date
August 30 2014
Last Update
July 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.